Agios on today’s phase 2 data for the pyruvate kinase activator mitapivat in sickle cell disease
Brian Goff, CEO of Agios Pharma, on today's phase 2 SCD data and how he thinks maitapivat can fit into the competitive landscape.
Also look for unique social pages for BiotechTV U.
At Savills, the Life Sciences Team specializes in helping biotech companies unlock their full potential by aligning real estate strategies with their scientific and business goals. As a leading global commercial real estate advisory firm, we focus exclusively on occupier services and tenant representation, acting as a trusted partner to some of the most innovative companies in the industry.